Literature DB >> 8831087

Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.

W H Nikolaizik1, V Jenni-Galović, M H Schöni.   

Abstract

UNLABELLED: To assess the airway response to inhaled tobramycin we measured flow volume curves in 12 patients with cystic fibrosis. Immediately and/or 2 min after tobramycin inhalations there was a significant fall in lung function regardless of the concentration used; isotonic saline caused similar obstruction but not a complete cessation of peripheral airflows. The baseline oxygen saturation was significantly correlated with the fall in lung function. Ten minutes after inhalation lung function tests returned to baseline values.
CONCLUSION: As salbutamol could significantly reduce airway obstruction tobramycin should always be inhaled in combination with a bronchodilator.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831087     DOI: 10.1007/bf01957914

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

2.  Spirometry in the evaluation of pulmonary function.

Authors:  J F Morris
Journal:  West J Med       Date:  1976-08

3.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

4.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

5.  Bronchial response to nebulized antibiotics in children with cystic fibrosis.

Authors:  H L Chua; G G Collis; P N Le Souëf
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

6.  Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Authors:  I B MacLusky; R Gold; M Corey; H Levison
Journal:  Pediatr Pulmonol       Date:  1989

7.  Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Authors:  B W Ramsey; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; R M Kravitz; D V Schidlow; R W Wilmott; S J Astley; M A McBurnie
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

8.  Comparison of efficacy of salbutamol and sodium cromoglycate in the prevention of ticarcillin-induced bronchoconstriction.

Authors:  H L Chua; S L Walker; P N LeSouëf; P D Sly
Journal:  Pediatr Pulmonol       Date:  1993-11

9.  Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.

Authors:  E Eber; B Oberwaldner; M S Zach
Journal:  Pediatr Pulmonol       Date:  1988
  9 in total
  5 in total

Review 1.  Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Edward Charbek
Journal:  Cochrane Database Syst Rev       Date:  2022-08-01

2.  A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.

Authors:  Alexander Chuchalin; Eszter Csiszér; Kàlmàn Gyurkovics; Maria Trawińska Bartnicka; Dorota Sands; Nikolai Kapranov; Guido Varoli; Pier Alessandro Monici Preti; Henryk Mazurek
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Edward Charbek
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30

Review 4.  Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Kate H Regan
Journal:  Cochrane Database Syst Rev       Date:  2018-03-30

5.  Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation.

Authors:  Timothy P Gauthier; Justin Wasko; Nathan R Unger; Lilian M Abbo; Margaret Fernandez; Laura Aragon
Journal:  Antibiotics (Basel)       Date:  2015-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.